Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts.
Doucet C, Brouty-Boyé D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. Doucet C, et al. Among authors: pottin clemenceau c. Int Immunol. 1998 Oct;10(10):1421-33. doi: 10.1093/intimm/10.10.1421. Int Immunol. 1998. PMID: 9796908
Effects of human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues on CD34+ stem cells.
Brouty-Boyé D, Briard D, Azzarone B, Le Bousse-Kerdilès MC, Clay D, Pottin-Clémenceau C, Jasmin C. Brouty-Boyé D, et al. Among authors: pottin clemenceau c. Int J Cancer. 2001 May 15;92(4):484-8. doi: 10.1002/ijc.1222. Int J Cancer. 2001. PMID: 11304681 Free article.
Chemokines and CD40 expression in human fibroblasts.
Brouty-Boyé D, Pottin-Clémenceau C, Doucet C, Jasmin C, Azzarone B. Brouty-Boyé D, et al. Among authors: pottin clemenceau c. Eur J Immunol. 2000 Mar;30(3):914-9. doi: 10.1002/1521-4141(200003)30:3<914::AID-IMMU914>3.0.CO;2-D. Eur J Immunol. 2000. PMID: 10741409 Free article.
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops.
Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boyé D, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B. Barzegar C, et al. Among authors: pottin clemenceau c. Oncogene. 1998 May 14;16(19):2503-12. doi: 10.1038/sj.onc.1201775. Oncogene. 1998. PMID: 9627116 Free article.
Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.
Doucet C, Brouty-Boyé D, Pottin-Clémenceau C, Canonica GW, Jasmin C, Azzarone B. Doucet C, et al. Among authors: pottin clemenceau c. J Clin Invest. 1998 May 15;101(10):2129-39. doi: 10.1172/JCI741. J Clin Invest. 1998. PMID: 9593769 Free PMC article.
Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C, Meazza R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Ferrini S, Alileche A, Taoufik Y, Jasmin C, Azzarone B, Indiveri F. Doucet C, et al. Among authors: pottin clemenceau c. Melanoma Res. 1997 Aug;7 Suppl 2:S7-17. Melanoma Res. 1997. PMID: 9578412
Are interleukin-2 and interleukin-15 tumor promoting factors for human non-hematopoietic cells?
Azzarone B, Pottin-Clemenceau C, Krief P, Rubinstein E, Jasmin C, Scudeletti M, Indiveri F. Azzarone B, et al. Among authors: pottin clemenceau c. Eur Cytokine Netw. 1996 Jan-Mar;7(1):27-36. Eur Cytokine Netw. 1996. PMID: 8704093 Review.
Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptor.
Han D, Plaisance S, Rubinstein E, Alileche A, Pottin-Clemenceau C, Kim TS, Cohen EP, Jasmin C, Azzarone B. Han D, et al. Among authors: pottin clemenceau c. Eur J Immunol. 1995 Jul;25(7):1905-12. doi: 10.1002/eji.1830250717. Eur J Immunol. 1995. PMID: 7621867
IL2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy.
Han D, Pottin-Clemenceau C, Imro MA, Scudeletti M, Doucet C, Puppo F, Brouty-Boye D, Vedrenne J, Sahraoui Y, Brailly H, Poggi A, Jasmin C, Azzarone B, Indiveri F. Han D, et al. Among authors: pottin clemenceau c. Oncogene. 1996 Mar 7;12(5):1015-23. Oncogene. 1996. PMID: 8649792
Feedback